logo
15:59 Dec 12

Hikal Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
252.71
-2.13 (-0.84%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Hikal Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
252.71
-2.13 (-0.84%)
15:59 Dec 12
Quality
image/svg+xml

73/100
High Financial Strength

Valuation
image/svg+xml

44/100
Mid Valuation

Technical

42/100
Technically Neutral

Strength

4

Weakness

9

Opportunity

1

Threats

0

7.19 %

ROE %

3.59 %

ROA %

0.82

EPS

102.21

BVPS

4.88 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM 2025
Net Sales
1942.72 2023.03 1784.6 1859.8 1699
Operating Expenses +
1602.16 1765.97 1517.57 1531.4 1471.2
Raw Material
1032.21 1121.59 805.15 882.7 824.2
Increase Decrease in Cost
-35.82 -14.56 19.51 -45.4 -68
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
203.38 222.44 246.53 247.1 260.4
Miscellaneous Expenses
402.39 436.5 446.38 447 454.6
Operating Profit
340.56 257.06 267.03 328.4 227.8
Other Income
4.89 5.41 2.45 5 7
Depreciation
95.67 109.01 117.61 134.4 151.5
Interest
31.22 48.1 56.37 75.2 68.6
Profit before tax and exceptio..
218.56 105.36 95.5 123.8 14.7
Exceptional Items
0 0 0 0 0
PBT
218.56 105.36 95.5 123.8 14.7
Provision for Taxation
58.06 26.98 25.9 33 4.6
Net Profit
160.5 78.38 69.6 90.8 10.1
NET Profit after MI
160.5 78.38 69.6 90.8 10.1
EPS
13.02 6.36 5.64 7.36 0.81
Operating Profit Margin (%)
17.53 12.71 14.96 17.66 13.41
Net Profit Margin (%)
8.26 3.87 3.9 4.88 0.59

Hikal Ltd. Shareholding

All Data in Percentage (%)
Promoter - - - - -
FII - - - - -
Public - - - - -
MF - - - - -
Others
Shareholder Shares Holding %
Research 360 logo
Download Our App On: